HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Carbenicillin

HCID 20824
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
4697-36-3
Standard SMILES
CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O
InChIKey
FPPNZSSZRUTDAP-UWFZAAFLSA-N
Molecular formula
C17H18N2O6S
Average molar mass
378.4 g/mol
Monoisotopic mass
378.08855747

Overview

Carbenicillin is a penicillin antibiotic having a 6beta-2-carboxy-2-phenylacetamido side-chain. It has a role as an antibacterial drug. It is a penicillin and a penicillin allergen. It is a conjugate acid of a carbenicillin(2-).

Names & identifiers

Preferred name
Carbenicillin
IUPAC
(2S,5R,6R)-6-[(2-carboxy-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
English name
CARBENICILLIN
Molecular formula
C17H18N2O6S
Molecular weight
378.4

Names & synonyms

carbenicillin4697-36-3CarboxybenzylpenicillinCarbenicilinaCarbenicillinealpha-CarboxybenzylpencillinCarbenicillinumCarbenicillinaCBPCalpha-Phenyl(carboxymethylpenicillin)6-(alpha-Carboxyphenylacetamido)penicillanic acidCHEBI:3393
Show more names
Pyocianilonamic acidARBENICILLINCARBENICILLIN USP/EP/BPLactic Acid Impurity 53CARBENICILLIN READY MADECarbenicillinum natricum(α-Carboxybenzyl)penicillin
G42ZU72N5G(2S,5R,6R)-6-[(2-carboxy-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid(2S,5R,6R)-6-(2-carboxy-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acidN-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamic acidDTXSID6048464Malonamic acid, N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenyl-N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamic acid4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxyphenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-

Properties

Computed structural propertiesFilling in

XLogP
1.1
Topological polar surface area
149 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
7
Rotatable bonds
5
Heavy atoms
26
Formal charge
0
Complexity
645

Experimental & physicochemical properties

DrugsPharmaceuticals -> Antibiotics
pHPH: (1% SOLN, WT/VOL) BETWEEN 6.8 & 7.5
LogP · 2 items

logP = 1.13

1.8

Solubility · 2 items

WHITE TO OFF-WHITE, CRYSTALLINE POWDER; BITTER TASTE; HYGROSCOPIC; ODORLESS; PKA1: 2.76; PKA2: 3.5; SPECIFIC OPTICAL ROTATION: +175 TO +185 DEG; 1 G SOL IN 1.2 ML WATER, 25 ML ALCOHOL; SOL IN METHANOL, DIL ALKALI, DIL ACID; INSOL IN ACETONE, CHLOROFORM, ETHER /DISODIUM/

3.90e-01 g/L

Human DrugsBreast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Penicillins
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Physical DescriptionSolid
Stability/Shelf Life · 2 items

UNSTABLE IN ACID /DISODIUM/

Extended-spectrum penicillins are generally stable for several yr in the dry state @ room temp; however, the drugs are stable only for short periods of time in soln unless frozen. Like other penicillins, stability of extended-spectrum penicillins is pH and temp dependent ... carbenicillin indanyl sodium is more resistant to acid-catalyzed hydrolysis than carbenicillin and is generally stable in the presence of acidic gastric secretions following oral admin.

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationREACH registered substance: CBPC (EC: 434-340-1)
Other Safety InformationIMAP assessments - 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(carboxyphenylacetyl)amino]-3,3-dimethyl-7-oxo-, [2S-(2.alpha.,5.alpha.,6.beta.)]-: Environment tier I assessment
FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Hazard Classes and CategoriesSkin Sens. 1 (100%)

Safety & protection

Storage ConditionsCarbenicillin indanyl sodium tablets should be protected from moisture and stored in tight containers at a temperature not exceeding 30 °C. /Carbenicillin indanyl sodium/

Chemistry & industry

Pharmacology

ATC Code · 2 items

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Protein Binding30 to 60%
Pharmacodynamics · 1 item

Carbenicillin is a semisynthetic penicillin. Though carbenicillin provides substantial <i>in vitro</i> activity against a variety of both gram-positive and gram-negative microorganisms, the most important aspect of its profile is in its antipseudomonal and antiproteal activity. Because of the high urine levels obtained following administration, carbenicillin has demonstrated clinical efficacy in urinary infections due to susceptible strains of: <i>Escherichia coli</i>, <i>Proteus mirabilis</i>, <i>Proteus vulgaris</i>, <i>Morganella morganii</i>, <i>Pseudomonas</i> species, <i>Providencia rettgeri</i>, <i>Enterobacter</i> species, and <i>Enterococci</i> (<i>S. faecalis</i>).

Mechanism of Action · 3 items

Free carbenicillin is the predominant pharmacologically active fraction of the salt. Carbenicillin exerts its antibacterial activity by interference with final cell wall synthesis of susceptible bacteria. Penicillins acylate the penicillin-sensitive transpeptidase C-terminal domain by opening the lactam ring. This inactivation of the enzyme prevents the formation of a cross-link of two linear peptidoglycan strands, inhibiting the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that carbenicillin interferes with an autolysin inhibitor.

The penicillins and their metabolites are potent immunogens because of their ability to combine with proteins and act as haptens for acute antibody-mediated reactions. The most frequent (about 95 percent) or "major" determinant of penicillin allergy is the penicilloyl determinant produced by opening the beta-lactam ring of the penicillin. This allows linkage of the penicillin to protein at the amide group. "Minor" determinants (less frequent) are the other metabolites formed, including native penicillin and penicilloic acids. /Penicillins/

Bactericidal; inhibit bacterial cell wall synthesis. Action is dependent on the ability of penicillins to reach and bind penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. Penicillin-binding proteins (which include transpeptidases, carboxypeptidases, and endopeptidases) are enzymes that are involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Penicillins bind to, and inactivate, penicillin-binding proteins, resulting in the weakening of the bacterial cell wall and lysis. /Penicillins/

Related reactions

7 records
New reaction record
HRID 519254 reaction equation
HRID 519254As reactant
HRID 644586 reaction equation
HRID 644586As reactant
HRID 713537 reaction equation
HRID 713537As reactant
HRID 1833409 reaction equation
HRID 1833409As product
HRID 1879592 reaction equation
HRID 1879592As reactant
HRID 2195620 reaction equation
HRID 2195620As reactant
HRID 2215888 reaction equation
HRID 2215888As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
4697-36-3
PubChem CID
20824
DTXSID
DTXSID6048464
ChEMBL
CHEMBL1214
ChEBI
CHEBI:3393
UNII
G42ZU72N5G
EC Number
225-171-0、434-340-1
Nikkaji
J3.066J

Physicochemical properties

Boiling point
737.8 · 737.8±60.0 °C(Predicted)
Density
1.53 · 1.53±0.1 g/cm3(Predicted)
storage temp.
20 °C · −20°C
solubility
Soluble in DMSO
form
Powder
pka
2.22 · pKa 2.22±0.05(H2O t = 25.0 I = 0.15 (KCl)) (Uncertain);3.25±0.02 (Uncertain)
Water Solubility
2 O: · H2O: 100mg/mLethanol: 100mg/mL
InChIKey
FPPNZSSZRUTDAP-UWFZAAFLSA-N
SMILES
CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O
CAS DataBase Reference
4697 · 4697-36-3
FDA UNII
42 ZU72N5G · G42ZU72N5G
ATC code
1 CA03 · J01CA03
UNSPSC Code
51282404 · 51282404
NACRES
85 · NA.85
Symbol(GHS)
8 · GHS08
Signal word
Danger
Hazard statements
334 · H334-H317
Precautionary statements
261 · P261-P285-P304+P341-P342+P311-P501-P261-P272-P280-P302+P352-P333+P313-P321-P363-P501
PPE
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Hazard Codes
Xn
Risk Statements
10 · 10-42/43
Safety Statements
36 · 36/37-45-22
RIDADR
1170 · UN 1170 3/PG 3
WGK Germany
2 · 2
Storage Class
3 · 3 - Flammable liquids
Hazard Classifications
3 Resp · Flam. Liq. 3Resp. Sens. 1Skin Sens. 1
Hazardous Substances Data
4697 · 4697-36-3(Hazardous Substances Data)
Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Toxicology

Interactions · 5 items

Extended-spectrum penicillins are physically and/or chemically incompatible with aminoglycosides and can inactivate the drugs in vitro. The extent of in vitro inactivation of aminoglycosides by penicillins depends on the specific drugs involved and appears to be directly proportional to the penicillin concn, length of exposure, and temp ... Most in vitro studies indicate that carbenicillin ... inactivates aminoglycosides at a faster rate than mazlocillin, piperacillin, or ticarcillin.

Extended-spectrum penicillins can also inactivate aminoglycosides in vivo. In patients with impaired renal function, concomitant admin of carbenicillin ... and gentamicin has resulted in decreased serum aminoglycoside concn and serum half-lives compared with admin of the aminoglycoside alone.

Some in vitro studies indicate that the antibacterial activity of extended-spectrum penicillins may be additive or partially synergistic with other beta-lactam antibiotics ... . /Extended-spectrum penicillins/

In vitro studies indicate that the combination of carbenicillin ... with clavulanic acid, a beta-lactamase inhibitor, results in a synergistic bactericidal effect against many strains of beta-lactamase-producing bacteria.

For more Interactions (Complete) data for CARBENICILLIN (7 total), please visit the HSDB record page.

Human Toxicity Excerpts · 5 items

MASSIVE IV DOSES IN MAN...MAY RESULT IN AN ENCEPHALOPATHY WITH MUSCULAR HYPERIRRITABILITY, MYOCLONUS, VISUAL & AUDITORY HALLUCINATIONS & GENERALIZED CONVULSIONS. ... ALLERGIC REACTIONS ARE FAR MORE COMMON THAN FRANK TOXICITY. ANAPHYLACTIC SHOCK IS RARE, BUT CAN FOLLOW ONE-MICROGRAM TEST DOSE. /PENICILLINS/

SKIN RASHES OF ALL TYPES HAVE BEEN OBSERVED WHEN PENICILLIN SENSITIZATION HAS OCCURRED. ...VESICULAR, & BULLOUS ERUPTIONS MAY DEVELOP. PURPURIC LESIONS ARE UNCOMMON & ARE USUALLY RESULT OF VASCULITIS; THROMBOPENIC PURPURA MAY OCCUR VERY RARELY. HENOCH-SCHOENLEIN PURPURA WITH RENAL INVOLVEMENT HAS BEEN RARE... /PENICILLINS/

CONTACT DERMATITIS IS OBSERVED...IN PHARMACISTS, NURSES, & PHYSICIANS WHO PREPARE PENICILLIN SOLN... MORE SEVERE REACTIONS INVOLVING SKIN ARE EXFOLIATIVE DERMATITIS & EXUDATIVE ERYTHEMA MULTIFORME OF EITHER ERYTHEMATOPAPULAR OR VESICULOBULLOUS TYPE...CONSTITUTE CHARACTERISTIC STEVENS-JOHNSON SYNDROME. /PENICILLINS/

VARIETY OF ORAL LESIONS HAVE RESULTED FROM SENSITIZATION TO PENICILLIN. AMONG THESE ARE ACUTE GLOSSITIS, SEVERE STOMATITIS WITH LOSS OF BUCCAL MUCOUS MEMBRANES, FURRED TONGUE, BLACK OR BROWN TONGUE, & CHEILOSIS. /PENICILLINS/

For more Human Toxicity Excerpts (Complete) data for CARBENICILLIN (48 total), please visit the HSDB record page.

Drug Induced Liver Injury · 5 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

carbenicillin

DILI Positive

Oral

DOI:10.1016/j.drudis.2019.09.022

Non-Human Toxicity Excerpts · 5 items

DEATH FROM RESP FAILURE WITH OR WITHOUT CONVULSIONS OCCURRED 6-18 HR AFTER SINGLE ORAL DOSES /TO MICE, RATS, RABBITS/. ACUTE GASTROENTERITIS & CARDIOVASCULAR SHOCK... /PENICILLINS/

IN HAMSTERS DRUG IS SOMEWHAT MORE TOXIC BY ORAL THAN BY SC ROUTE WHEN OBSERVED FOR 14 DAYS AFTER SINGLE DOSES. ... PERHAPS SENSITIVITY OF GUINEA PIGS IS RELATED TO EFFECTS ON INTESTINAL MICROFLORA. /PENICILLINS/

...ENCEPHALOPATHY WITH MUSCULAR HYPERIRRITABILITY, MYOCLONUS, VISUAL & AUDITORY HALLUCINATIONS & GENERALIZED CONVULSIONS. ...ELICITED IN RATS & CATS WITH DOSES TO 3-4 MILLION UNITS/KG... /PENICILLINS/

IT HAD FEW SIDE EFFECTS WHEN GIVEN REPEATEDLY TO MICE, RATS, & CATS. IV LD50 VALUE FOR MICE WAS 47 MG/20 G. SC ADMIN OF 250 OR 1000 MG/KG TO RATS HAD NO SIDE EFFECTS. IN CATS, 300-500 MG/KG DECR ARTERIAL PRESSURE.

DEATH FROM RESP FAILURE WITH OR WITHOUT CONVULSIONS OCCURRED 6-18 HR AFTER SINGLE ORAL DOSES /TO CATS & DOGS/. ACUTE GASTROENTERITIS & CARDIOVASCULAR SHOCK...ALSO TRUE FOR GUINEA PIGS EXCEPT THAT A LATE...& GRADUALLY DEVELOPING TOXEMIA KILLED ALL SURVIVORS OF ACUTE RESPONSE. /PENICILLINS/

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Regulatory information

FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Safety data

PPE
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
wgk
2
ridadr
UN 1170 3/PG 3
risk_code
10-42/43
Signal word
Danger
Symbol(GHS)
GHS08
hazard_code
Xn
safety_code
36/37-45-22
Storage Class
3 - Flammable liquids
Hazard statements
H334-H317
Hazard Classifications
Flam. Liq. 3Resp. Sens. 1Skin Sens. 1
Precautionary statements
P261-P285-P304+P341-P342+P311-P501-P261-P272-P280-P302+P352-P333+P313-P321-P363-P501
Hazardous Substances Data
4697-36-3(Hazardous Substances Data)
Biological Half-Life · 2 items

1 hour

...T 1/2...IN INDIVIDUALS WITH NORMAL RENAL FUNCTION IS ABOUT 1 HR...PROLONGED TO ABOUT 2 HR IN PRESENCE OF HEPATIC DYSFUNCTION.

Metabolism/MetabolitesMinimal.
FDA Pharmacological Classification · 5 items

G42ZU72N5G

CARBENICILLIN

Established Pharmacologic Class [EPC] - Penicillin-class Antibacterial

Chemical Structure [CS] - Penicillins

Carbenicillin is a Penicillin-class Antibacterial.

MeSH Pharmacological ClassificationSubstances that inhibit the growth or reproduction of BACTERIA.
Absorption, Distribution and Excretion · 6 items

Rapidly absorbed from the small intestine following oral administration. Oral bioavailability is 30 to 40%.

CARBENICILLIN IS NOT ABSORBED FROM GI TRACT &, THEREFORE MUST BE GIVEN PARENTERALLY. ... IM INJECTION OF 1 G PRODUCES PEAK PLASMA CONCN OF 15-20 UG/ML IN 1/2-2 HR... MAX PLASMA CONCN ARE ABOUT 4 TIMES HIGHER AFTER IV THAN AFTER IM ADMIN... IV INFUSION...1 G/HR RESULTS IN AVG PLASMA CONCN OF APPROX 150 UG/ML.

ABOUT 50% OF ANTIBIOTIC IN PLASMA IS PROTEIN BOUND. ...CARBENICILLIN IS EXCRETED PRIMARILY BY RENAL TUBULES. ABOUT 75-80%...IS RECOVERABLE IN ACTIVE FORM IN URINE IN 9 HR.

Carbenicillin is not stable in acids nor does it resist penicillinases; thus it is administered parenterally because of poor absorption following oral administration. A parenteral dose of 50-200 mg/kg is divided for administration every 4-6 hr.

Although carbenicillin is eliminated from the bovine mammary gland within 72 hr posttreatment, mastitis produced by P. aeruginosa is not effectively treated; resistant organisms are recovered 24-48 hr postinfusion.

For more Absorption, Distribution and Excretion (Complete) data for CARBENICILLIN (11 total), please visit the HSDB record page.

Cellular LocationsMembrane

Uses & manufacturing

UsesMEDICATION
U.S. Imports · 2 items

(1976) 1.4X10+5 G-PRINCPL CUSTMS DIST-DISODIUM

(1979) 4.7X10+6 G-PRINCPL CUSTMS DIST-DISODIUM

U.S. Production · 2 items

(1977) PROBABLY MORE THAN 9.07X10+5 G-DISODIUM

(1979) PROBABLY MORE THAN 9.07X10+5 G-DISODIUM

Consumption PatternsESSENTIALLY 100% AS AN ANTIBIOTIC (AS DISODIUM SALT)
Methods of ManufacturingACYLATION OF 6-AMINOPENICILLANIC ACID WITH MONOESTERS OF PHENYLMALONIC ACID FOLLOWED BY SAPONIFICATION WITH THE AID OF ALPHA-CHYMOTRYPSIN OR PANCREATIN
Formulations/PreparationsBRL-2064, CARBENICILLIN DISODIUM, CP-15-639-2, ANABACTYL, CARBAPEN, CARBECIN, GEOPEN, HYOPER, MICROCILLIN, PYOCIANIL, PYOPEN /DISODIUM/
Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
General Manufacturing Information · 2 items

THIS DRUG IS PENICILLINASE-SUSCEPTIBLE DERIVATIVE OF 6-AMINOPENICILLANIC ACID.

PREPN OF DISODIUM SALT: BELG PATENT 646,991, CORRRESPONDING TO BRAIN, NAYLER, US PATENT 3,282,926 (1964 & 1966 TO BEECHAM).

Applications

UsesAntibacterial.

Upstream & downstream products

Upstream raw materials

6-Aminopenicillanic acidHydrogenPhenylmalonic acidThionyl chlorideBenzyl alcoholSodium bicarbonate

Additional notes

DefinitionChEBI: A penicillin antibiotic having a 6beta-2-carboxy-2-phenylacetamido side-chain.